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Abstract 
The paper describes an efficient methodology for the synthesis of diversely 
functionalized dihydrodibenzo[b,e]azepin-11-ones based on the Pd(0)-catalyzed 








Palladium-catalyzed coupling reactions are well-established as reliable carbon-
carbon bond-forming tools both in the research labor tory and in large-scale industrial 
production.1 Among the variety of available cross-coupling processes, the palladium-
catalyzed nucleophilic additions of aryl halides2-8 and arylboronic acids9-13 to carbon-
heteroatom multiple bonds have been attracting increasing interest in recent years and 
are now emerging as powerful synthetic methodologies. 
As part of our ongoing research on the synthesis of nitrogen heterocycles by means of 
palladium-catalyzed intramolecular coupling reactions of aryl halides and carbonyl 
compounds,14 we have been studying the possibility of controlling the ambiphilic 
character of the σ-arylpalladium species involved in these reactions.7,8,15,16 In this 
context, we have recently reported that when starting from (2-iodoanilino) aldehydes, 
both the enolate arylation and the acylation of the aryl halide can also be selectively 
promoted by Pd(0) with only a slight modification of the reaction conditions.17 The 
latter acylation reaction seems to proceed through a mechanism involving a 
carbopalladation between the σ-arylpalladium(II) moiety and the carbonyl group, 
followed by a β-hydride elimination from the resulting Pd(II) alkoxide intermediate. 
Besides its mechanistic implications, this reaction has considerable synthetic interest 
because it could constitute an alternative to classic l acylation methodologies such as 
the Friedel-Crafts reaction, whose intrinsic problems of regioselectivity often decrease 
its effectiveness in the synthesis of unsymmetrically substituted derivatives.18 
Moreover, it also provides an alternative to our previously reported palladium-catalyzed 
acylation of aryl halides by esters7 and amides.8 As these palladium-catalyzed reactions 
involve the nucleophilic attack of the σ-arylpalladium(II) species at the carbonyl group, 
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the use of the more electrophilic aldehydes as the acylating agents would result in a 
more efficient methodology. 
To demonstrate the potential of the palladium-catalyzed acylation reaction with 
aldehydes,3,19 we envisioned the synthesis of polycyclic compounds containing the 
dibenzo[b,e]azepine moiety (Scheme 1). The dibenzo[b,e]azepine system has attracted 
considerable attention due to its ubiquitous presence i  the molecular structure of 
important bioactive compounds.20 Therefore, the development of reliable methodologies 
for the construction of the dibenzo[b,e]azepine skeleton would be highly useful in the 
field of synthetic organic chemistry.21 In particular, palladium-catalyzed annulation 















We commenced our investigation by studying the acylation reactions of aldehydes 1a
and 1b (Table 1). We were pleased to find that starting from iodoaniline 1a, the 
acylation can be smoothly promoted by using 5 mol % of Pd2(dba)3, 10 mol % of the 
phosphine ligand, and Cs2CO3 as the base in toluene at high temperature. As also 
observed in our initial studies with (2-iodoanilino) aldehydes,17 sterically hindered 
phosphines (i. e. dtpf, tBu3P and (o-tolyl)3P) proved to be highly efficient ligands for the 
acylation, and afforded dihydrodibenzo[b,e]azepin-11-one 1123 in 75% average yield 
(table 1, entries 1-3). The use of the same combination of catalyst and base in either 
acetonitrile or DMF was found to be less effective in promoting the acylation reaction 
(entries 4 and 5). Bromide 1b was less efficient than iodide 1a in the annulation 
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reaction, and longer reaction times were required to reach the total conversion of the 
starting material (entries 6-8). 
Although the acylation can be carried out effectively in toluene under simple thermal 
heating, the long reaction times required for the full conversion of the starting material, 
especially when starting from bromide 1b, prompted us to also explore the reaction 
under microwave irradiation (entries 9-13). 









X = I, 1a
X = Br, 1b 11  
entry aldehyde ligand solvent time 1H NMR ratio yield (%)a 
1 1a dtpf tolueneb 24 h  11 (77%) 
2 1a (tBu)3P·HBF4 toluene
b 24 h  11 (71%) 
3 1a (o-tolyl)3P toluene
b 36 h  11 (75%) 
4 1a dtpf CH3CN
b 24 h  11 (32%) 
5 1a dtpf DMFb 24 h  11 (34%) 
6 1b dtpfc tolueneb 36 h 1b:11 (5:1)  
7 1b (tBu)3P·HBF4
c tolueneb 72 h 1b:11 (1:1.1)  
8 1b (o-tolyl)3P
c tolueneb 120 h  11 (48%) 
9 1a dtpf toluened 60 min 1a:11 (3:1)  
10 1a dtpf dioxaned 60 min 1a:11 (3.5:1)  
11 1a dtpf DMFd 30 min  11 (35%) 
12 1b dtpf DMFd 30 min  11 (37%) 
13 1b dtpf CH3CN
d 30 min  11 (34%) 
a Yields refer to pure products isolated by flash chromatography. b The reactions were carried 
out using Pd2(dba)3 (0.05 equiv), ligand (0.1 equiv), Cs2CO3 (3 equiv) and Et3N (6 equiv) in the 
indicated solvent at 110 ºC in a sealed tube. c 0.075 equiv of Pd2(dba)3 and 0.15 equiv of ligand 
were used. d The reactions were carried out using Pd2(dba)3 (0.05 equiv), ligand (0.1 equiv), 
Cs2CO3 (1 equiv) and Et3N (3 equiv) in the indicated solvent at 120 ºC in a se led vessel in a 
microwave reactor (fixed temperature, variable pressure). 
 
Under microwave-mediated heating, the use of low absorbing solvents24 such as toluene 
and dioxane resulted in poor conversions (entries 9-10). On the other hand, when using 
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DMF as the solvent, although the starting material was completely consumed in 30 min, 
dibenzoazepinone 11 was obtained in low yield (entries 11-12). Similar results were 
obtained when using K3PO4 or KOAc as the base instead of Cs2 O3, and (o-tolyl)3P or 
tBu3P as the ligand (not shown in the table). Performing the reaction in acetonitrile also 
resulted in the complete conversion of the starting material, but 11 was again isolated 
only in modest yield (entry 13). It should be noted, however, that none of the 
experiments summarized in Table 1 yielded any observable products other than ketone 
11 or the non-reacted starting material. 
To compare the effectiveness of the palladium-catalyzed acylation with aldehydes with 
our previously reported procedure using esters as the acylating agents, we decided to 
prepare ester 1c (Scheme 2). 1c failed to undergo acylation reaction when submitted o 
the conditions optimized with esters [Pd(PPh3)4 and K3PO4 in toluene at 110 ºC]
7 as 
well as to the new reaction conditions [Pd2(dba)3/ligand (dtpf, or (o-tolyl)3P) and 
Cs2CO3 in toluene at 110 ºC]. In all the experiments only minor amounts of the 
















As shown in Tables 2 and 3, a variety of diversely substituted substrates was 
investigated under the standard thermal heating conditi s using toluene as the solvent. 
 
























R1 = Bn, R2 = Me, R3 = R4 = H, 2
R1 = Me, R2 = MeO, R3 = R4 = H, 3
R1 = Me, R2 = R4 = H, R3 = F, 4a
R1 = Me, R2 = R4 = H, R3 = Cl, 4b
R1 = Me, R2 = R4 = H, R3 = CH2OH, 4c
R1 = Me, R2 = R4 = H, R3 =CHO, 4d
R1 = Me, R2 = R4 = H, R3 = CH2OAc, 4e
R1 = Me, R2 = R4 = H, R3 = CH2NMe2, 4f
R1 = Me, R2 = R3 = H, R4 = F, 5




entry aldehyde ligand time yield (%)b 
1 2 dtpf 24 h 12 (91%) 
2 2 (tBu)3P·HBF4 24 h 12 (77%)
c 
3 2 (o-tolyl)3P 36 h 12 (62%) 
4 3 dtpf 36 h 13 (60%) 
5 3 (tBu)3P·HBF4 48 h 13 (55%) 
6 3 (o-tolyl)3P 48 h 13 (51%) 
7 4a dtpf 48 h 14a (74%) 
8 4a (tBu)3P·HBF4 60 h 14a (71%) 
9 4b dtpf 36 h 14b (60%)d 
10 4b (tBu)3P·HBF4 72 h 14b (79%) 
11 4b (o-tolyl)3P 72 h 14b (65%)
d 
12 4c dtpf 24 h 14c (71%)e 
13 4c (tBu)3P·HBF4 24 h 14 c (53%)
f 
14 4d dtpf 36 h 14d (53%) 
15 4d (tBu)3P·HBF4 48 h 14d (46%) 
16 4e dtpf 24 h 14e (59%) 
17 4e (tBu)3P·HBF4 48 h 14e (67%) 
18 4f dtpf 24 h 14f (69%) 
19 5 dtpf 36 h 15 (87%) 
20 5 (tBu)3P·HBF4 36 h 15 (72%) 
21 5 (o-tolyl)3P 36 h 15 (55%) 
22 6 dtpf 24 h --- 
23 6 (o-tolyl)3P 24 h --- 
a The reactions were carried out using Pd2(dba)3 (0.05 equiv), ligand (0.1 equiv), Cs2CO3 (3 
equiv) and Et3N (6 equiv) in toluene at 110 ºC in a sealed tube. 
b Yields refer to pure products 
isolated by flash chromatography. c Traces of 2 (≤ 5%) were also observed in the crude reaction 
mixture. d Traces of 5 (≤ 5%) were also observed in the crude reaction mixture. e 14d (9%) was 
also isolated. f 14d (15%) was also isolated. 
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In general, the introduction of substituents on the aniline ring (Table 1) had little effect 
on the success of the acylation reaction. Thus, the nucleophilicity of the aryl palladium 
intermediate does not appear to be significantly affected by the electronic properties of 
the substituent on the aromatic ring. Interestingly, the same behavior has also been 
observed in the closely related palladium-catalyzed acylation reaction with esters.7 The 
functional group tolerance of the reaction is well illustrated by the fact that halides, 
ethers, esters, aldehydes, free hydroxyl and dimethylamino groups all were perfectly 
accommodated. I should be noted, however, that in the acylation reactions of 4c, minor 
amounts of aldehyde 14d, resulting from the palladium-catalyzed oxidation f alcohol 
14c,17 were also isolated. The successful preparation of 14f indicates that the Pd 
catalytic species are not deactivated by the presenc  of strong coordinating 
dialkylamino group. 
The effect of the substituent at the aniline nitrogen atom was also examined. While the 
methyl and benzyl groups were well tolerated in the acylation reaction, changing the 
substituent at the nitrogen from alkyl to the electron-withdrawing tert-butoxycarbonyl 
group resulted in the formation of complex reaction mixtures in which no acylation 
compound could be identified (entries 22 and 23). 
The palladium-catalyzed acylation was also extended to the preparation of naphtho-
fused derivatives, which are attractive for their potential antitumor activity.20a As can be 
seen in Table 3, both iodoanilines and iodonaphthylamines can be used for this purpose, 
although the acylation from the latter proceeded more slowly. 
Regarding ligands, as shown in Tables 1-3, the three st rically hindered phosphines 
used in this work proved to be similarly effective in promoting the acylation reaction. 
On the whole, dtpf25 seems to be the most versatile ligand, despite not always giving the 
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highest yield. On the other hand, the use of (o-tolyl)3P as the ligand usually resulted in 
lower reaction rates, as reflected in the longer reaction times required for the complete 
consumption of the starting material. 
TABLE 3. Synthesis of tetracyclic ketonesa 













1 7 dtpfc 16 (61%) 
2 7 (tBu)3P·HBF4











3 8 dtpfc 17 (58%) 
4 8 (tBu)3P·HBF4 17 (33%) 












6 9 dtpf 18 (70%) 
7 9 (tBu)3P·HBF4 18 (87%) 











9 10 dtpfc 19 (64%) 
10 10 (tBu)3P·HBF4 19 (63%) 
11 10 (o-tolyl)3P 10 + 19 (1.5:1)
d 
a The reactions were carried out using Pd2(dba)3 (0.05 equiv), ligand (0.1 equiv), Cs2CO3 (3 
equiv) and Et3N (6 equiv) in toluene at 110 ºC for 72 h in a sealed tube. 
b Yields refer to pure 
products isolated by flash chromatography. c 24 h. d 1H NMR ratio, yield not quantified. 
In summary, we have demonstrated that the palladium-catalyzed intramolecular 
acylaton of aryl iodides with aldehydes constitutes an efficient methodology for the 
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synthesis of dihydrodibenzo[b,e]azepin-11-ones. The present reaction is a valuable 
synthetic alternative to our previously reported palladium-catalyzed acylation of aryl 
halides by esters and amides. 
 
Experimental Section 
General Methods. Chromatography refers to flash chromatography on silica 
gel. 1H- and 13C NMR spectra were recorded in CDCl3 solution. Chemical shifts are 
reported in ppm downfield (δ) from Me4Si. 
2-[N-(2-Iodophenyl)-N-methylaminomethyl]benzaldehyde (1a). A mixture of 2-
iodo-N-methylaniline26 (0.25 g, 1.07 mmol), K2CO3 (0.23 g, 1.62 mmol), and 2-
(bromomethyl)benzonitrile (0.21 g, 1.07 mmol) in acetonitrile (20 mL) was stirred at 
reflux for 120 h: every 24 h a new portion of 2-(bromomethyl)benzonitrile (0.1 g, 0.51 
mmol) was added. The mixture was concentrated, and the residue was partitioned 
between water and CH2Cl2. The organic layer was dried and concentrated. The residue 
was purified by chromatography (from hexanes to 97:3 hexanes-EtOAc) to give 2-[N-
(2-iodophenyl)-N-methylaminomethyl]benzonitrile (315 mg, 85%). 
To a cooled (0ºC) solution of 2-[N-(2-iodophenyl)-N-methylaminomethyl]benzonitrile 
(315 mg, 0.9 mmol) in CH2Cl2 (5 mL), a 1.0 M solution of DIBAL-H in hexanes (1.35 
mL, 1.35 mmol) was added drop-wise under Argon. Theresulting solution was stirred 
at room temperature for 3 h, cooled again, and poured into a mixture of ice and 6 N 
HCl. The mixture was vigorously stirred for 1 h and then extracted with CH2Cl2. The 
organic extracts were washed with 1 N NaHCO3 aqueous solution, dried and 
concentrated. The residue was purified by chromatogr phy (from hexanes to 97:3 
hexanes-EtOAc) to give 1a (140 mg, 44%) as a yellow oil. 1H NMR (300 MHz) δ 2.67 
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(s, 3H), 4.57 (s, 2H), 6.81 (ddd, J = 7.8, 7.2, 1.5 Hz, 1H), 7.18 (dd, J = 8.1, 1.5 Hz, 1H), 
7.32 (ddd, J = 7.8, 7.2, 1.5 Hz, 1H), 7.43 (t, J = 7.2 Hz, 1H), 7.58 (td, J = 7.5, 1.5 Hz, 
1H), 7.77 (d, J = 7.5 Hz, 1H), 7.84-7.90 (m, 2H), 10.30 (s, 1H). 13C NMR (75.4 MHz) δ 
42.8, 57.2, 98.5, 122.4, 125.8, 127.5, 129.0, 130.4, 131.5, 133.5, 134.3, 140.1, 140.6, 
153.7, 192.6. IR (NaCl) ν 1693 cm-1. HRMS (ESI-TOF) cald for C15H15INO: 352.0193 
[M+H] +; found: 352.0191. 
2-[N-(2-Bromophenyl)-N-methylaminomethyl]benzaldehyde (1b). A mixture of 2-
bromoaniline (0.5 g, 2.9 mmol), K2CO3 (0.6 g, 4.35 mmol), and 2-
(bromomethyl)benzonitrile (0.57 g, 2.9 mmol) in acetonitrile (40 mL) was stirred at 
reflux for 24 h. The mixture was concentrated, and the residue was partitioned between 
water and CH2Cl2. The organic layer was dried and concentrated. The residue was 
purified by chromatography (CH2Cl2) to give 2-[N-(2-
bromophenyl)aminomethyl]benzonitrile (0.54 g, 65%). 
A mixture of 2-[N-(2-bromophenyl)aminomethyl]benzonitrile (0.54 g, 1.88 mmol), 
K2CO3 (0.52 g, 3.76 mmol), and iodomethane (1.0 mL, 16.0 mmol) in acetonitrile (5 
mL) was stirred at 80°C in a sealed tube for 2 days. The mixture was concentrated, and 
the residue was partitioned between water and CH2Cl2. The organic layer was dried and 
concentrated. The residue was purified by chromatogr phy (from hexanes to 95:5 
hexanes-EtOAc) to give 2-[N-(2-bromophenyl)-N-methylaminomethyl]benzonitrile 
(0.39 g, 69%). 
1b (140 mg, 54%) was obtained starting from 2-[N-(2-bromophenyl)-N-
methylaminomethyl]benzonitrile (0.26 g, 0.86 mmol) and operating as in the 
preparation of 1a. Chromatography: from hexanes to 95:5 hexanes-EtOAc. Brown solid. 
1H NMR (400 MHz) δ 2.69 (s, 3H), 4.60 (s, 2H), 6.92 (ddd, J = 8.4, 7.6, 1.6 Hz, 1H), 
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7.16 (dd, J = 8.0, 1.6 Hz, 1H), 7.26 (m, 1H), 7.43 (t, J = 8.0 Hz, 1H), 7.57 (d, J = 8.0 
Hz, 1H), 7.58 (t, J = 7.6 Hz, 1H), 7.78 (d, J = 7.6 Hz, 1H), 7.86 (d, J = 8.0 Hz, 1H), 
10.27 (s, 1H). 13C NMR (100.5 MHz) δ 41.5, 57.0, 120.3, 122.3, 124.7, 127.4, 128.1, 
129.9, 131.8, 133.6, 133.9, 134.3, 140.9, 150.9, 192.6. IR (NaCl) ν 1693 cm-1. HRMS 
(ESI-TOF) cald for C15H15BrNO: 304.0332 [M+H]
+; found: 304.0333. 
Compounds 1c and 2 were prepared according to the preparation of 1a. 
Methyl 2-[N-(2-iodophenyl)-N-methylaminomethyl]benzoate (1c). Chromatography: 
from hexanes to 95:5 hexanes-EtOAc. Pale yellow oil. 1H NMR (300 MHz) δ 2.64 (s, 
3H), 3.84 (s, 3H), 4.53 (s, 2H), 6.78 (ddd, J = 8.1, 7.5, 1.5 Hz, 1H), 7.15 (dd, J = 8.1, 
1.5 Hz, 1H), 7.25-7.34 (m, 2H), 7.51 (td, J = 7.5, 1.5 Hz, 1H), 7.83-7.91 (m, 3H). 13C 
NMR (75.4 MHz) δ 42.5, 52.0, 58.4, 98.1, 122.2, 125.3, 126.6, 129.0, 129.7, 130.1, 
130.4, 131.8, 140.0, 140.1, 154.4, 168.0. HRMS (ESI-TOF) cald for C16H17INO2: 
382.0304 [M+H]+; found: 382.0306. 
2-[N-Benzyl-N-(2-iodo-4-methylphenyl)aminomethyl]benzaldehyde (2). 
Chromatography: from hexanes to 9:1 hexanes-EtOAc. Colorless oil. 1H NMR (300 
MHz) δ 2.21 (s, 3H), 4.11 (s, 2H), 4.49 (s, 2H), 6.83 (d, J = 7.8 Hz, 1H), 6.98 (dd, J = 
7.8, 2.1 Hz, 1H), 7.21-7.41 (m, 6H), 7.48 (td, J = 7.5, 1.5 Hz, 2H), 7.59 (d, J = 7.8 Hz, 
1H), 7.67 (dd, J = 2.1, 0.6 Hz, 1H), 7.80 (dd, J = 7.8, 1.5 Hz, 1H), 10.13 (s, 1H). 13C 
NMR (75.4 MHz) δ 20.2, 52.8, 59.0, 99.9, 124.2, 127.3, 127.4, 128.2, 129.1, 129.4, 
130.8, 130.9, 133.3, 134.4, 136.2, 137.3, 140.3, 140.4, 148.2, 192.3. IR (NaCl) ν 1693 
cm-1. HRMS (ESI-TOF) cald for C22H21INO: 442.0662 [M+H]
+; found: 442.0655. 
Compounds 3, 4a-c, 5 and 8-10 were prepared according to the preparation of 1b 
starting from the corresponding o-iodoarylamines.27-30 
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2-[N-(2-Iodo-4-methoxyphenyl)-N-methylaminomethyl]benzaldehyde (3). 
Chromatography: CH2Cl2. Brown solid. 
1H NMR (300 MHz) δ 2.59 (s, 3H), 3.75 (s, 
3H), 4.47 (s, 2H), 6.87 (dd, J = 8.7, 3.0 Hz, 1H), 7.10 (d, J = 8.7 Hz, 1H), 7.37 (d, J = 
3.0 Hz, 1H), 7.41 (td, J = 7.5, 0.9 Hz, 1H), 7.54 (td, J = 7.5, 1.5 Hz, 1H), 7.70 (d, J = 
7.5 Hz, 1H), 7.87 (dd, J = 7.5, 1.2 Hz, 1H), 10.34 (s, 1H). 13C NMR (75.4 MHz) δ 43.4, 
55.6, 57.5, 99.7, 114.8, 122.7, 124.6, 127.5, 130.6, 131.0, 133.4, 134.3, 140.7, 146.7, 
158.7, 192.6. IR (NaCl) ν 1693 cm-1. HRMS (ESI-TOF) cald for C16H17INO2: 382.0298 
[M+H] +; found: 382.0290. 
2-[N-(5-Fluoro-2-iodophenyl)-N-methylaminomethyl]benzaldehyde (4a). 
Chromatography: CH2Cl2. Yellow oil. 
1H NMR (300 MHz) δ 2.67 (s, 3H), 4.56 (s, 2H), 
6.59 (ddd, J = 8.7, 7.8, 3.0 Hz, 1H), 6.90 (dd, J = 10.5, 3.0 Hz, 1H), 7.45 (td, J = 7.5, 
1.2 Hz, 1H), 7.59 (td, J = 7.5, 1.5 Hz, 1H), 7.77 (dd, J = 8.7, 6.3 Hz, 1H), 7.78 (d, J = 
7.8 Hz, 1H), 7.87 (dd, J = 7.5, 1.5 Hz, 1H), 10.27 (s, 1H). 13C NMR (75.4 MHz) δ 42.5, 
57.2, 90.3 (d, J = 4.1 Hz), 109.9 (d, J = 23.0 Hz), 112.8 (d, J = 21.9 Hz), 127.6, 130.2, 
132.2, 133.6, 134.2, 140.1, 140.6 (d, J = 9.2 Hz), 155.5 (d, J = 8.1 Hz), 163.6 (d, J = 
248.0 Hz), 192.7. IR (NaCl) ν 1692 cm-1. HRMS (ESI-TOF) cald for C15H14FINO: 
370.0099 [M+H]+; found: 370.0110. 
2-[N-(5-Cloro-2-iodophenyl)-N-methylaminomethyl]benzaldehyde (4b). 
Chromatography: from hexanes to 95:5 hexanes-EtOAc. Yellow oil. 1H NMR (300 
MHz) δ 2.66 (s, 3H), 4.55 (s, 2H), 6.81 (dd, J = 8.1, 2.4 Hz, 1H), 7.14 (d, J = 2.4 Hz, 
1H), 7.47 (td, J = 7.8, 1.2 Hz, 1H), 7.59 (td, J = 7.8, 1.5 Hz, 1H), 7.75 (d, J = 8.1 Hz, 
1H), 7.78 (d, J = 7.8 Hz, 1H), 7.87 (dd, J = 7.8, 1.5 Hz, 1H), 10.27 (s, 1H). 13C NMR 
(75.4 MHz) δ 42.5, 57.2, 95.0, 122.8, 125.7, 127.6, 130.2, 132.2, 133.6, 134.2, 134.9, 
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140.2, 140.7, 155.1, 192.6. IR (NaCl) ν 1699 cm-1. HRMS (ESI-TOF) cald for 
C15H14ClINO: 385.9803 [M+H]
+; found: 385.9797. 
2-[N-(5-Hydroxymethyl-2-iodophenyl)-N-methylaminomethyl]benzaldehyde (4c). 
Chromatography: from CH2Cl2 to CH2Cl2-MeOH 1%. Colorless oil. 
1H NMR (400 
MHz) δ 1.98 (broad s, 1H), 2.65 (s, 3H), 4.55 (s, 2H), 4.63 (s, 2H), 6.81 (dd, J = 8.0, 2.0 
Hz, 1H), 7.19 (d, J = 2.0 Hz, 1H), 7.43 (td, J = 7.6, 0.8 Hz, 1H), 7.58 (td, J = 7.6, 1.6 
Hz, 1H), 7.77 (d, J = 7.6 Hz, 1H), 7.81 (d, J = 8.0 Hz, 1H), 7.86 (dd, J = 7.6, 1.6 Hz, 
1H), 10.25 (s, 1H). 13C NMR (100.5 MHz) δ 42.6, 57.2, 64.6, 96.9, 120.9, 124.3, 127.6, 
130.5, 131.5, 133.5, 134.3, 140.1, 140.6, 142.3, 15.9, 192.6. IR (NaCl) ν 1682, 3400 
cm-1. HRMS (ESI-TOF) cald for C16H17INO2: 382.0298 [M+H]
+; found: 382.0298. 
2-[N-(5-Formyl-2-iodophenyl)-N-methylaminomethyl]benzaldehyde (4d) was 
prepared from 4c (Swern oxidation). Chromatography: CH2Cl2. Yellow oil. 
1H NMR 
(400 MHz) δ 2.72 (s, 3H), 4.63 (s, 2H), 7.28 (dd, J = 8.4, 2.0 Hz, 1H), 7.46 (td, J = 7.6, 
0.8 Hz, 1H), 7.58 (td, J = 7.6, 1.6 Hz, 1H), 7.65 (d, J = 2.0 Hz, 1H), 7.77 (d, J = 8.0 Hz, 
1H), 7.88 (dd, J = 7.6, 1.6 Hz, 1H), 8.06 (d, J = 8.0 Hz, 1H), 9.95 (s, 1H), 10.29 (s, 1H). 
13C NMR (100.5 MHz) δ 42.5, 57.3, 106.7, 121.5, 126.8, 127.7, 130.3, 132.1, 133.6, 
134.2, 137.2, 140.0, 141.2, 154.9, 191.3, 192.6. IR (NaCl) ν 1681, 1704 cm-1. HRMS 
(ESI-TOF) cald for C16H15INO2: 380.0142 [M+H]
+; found: 380.0135. 
2-[N-(5-Acetoxymethyl-2-iodophenyl)-N-methylaminomethyl]benzaldehyde (4e) 
was prepared from 4c (AcCl). Chromatography: CH2Cl2. Pale yellow oil. 
1H NMR (400 
MHz) δ 2.11 (s, 3H), 2.67 (s, 3H), 4.56 (s, 2H), 5.03 (s, 2H), 6.81 (dd, J = 8.0, 1.6 Hz, 
1H), 7.15 (d, J = 1.6 Hz, 1H), 7.43 (t, J = 7.6 Hz, 1H), 7.57 (td, J = 7.6, 1.6 Hz, 1H), 
7.77 (d, J = 7.6 Hz, 1H), 7.82 (d, J = 8.0 Hz, 1H), 7.87 (dd, J = 7.6, 1.2 Hz, 1H), 10.28 
(s, 1H). 13C NMR (100.5 MHz) δ 20.9, 42.6, 57.2, 65.5, 97.8, 122.1, 125.5, 127.5, 
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130.4, 131.6, 133.5, 134.3, 137.2, 140.3, 140.4, 153.9, 170.6, 192.6. IR (NaCl) ν 1693, 




(4f) was prepared from 4c (a. MsCl, b. Me2NH). Chromatography: from CH2Cl2 to 
CH2Cl2-MeOH 8%. Brown oil. 
1H NMR (400 MHz) δ 2.29 (s, 6H), 2.68 (s, 3H), 3.46 
(s, 2H), 4.58 (s, 2H), 6.77 (dd, J = 8.0, 2.0 Hz, 1H), 7.22 (s, 1H), 7.42 (t, J = 7.6 Hz, 
1H), 7.55 (td, J = 7.6, 1.6 Hz, 1H), 7.75 (d, J = 7.6 Hz, 1H), 7.79 (d, J = 8.0 Hz, 1H), 
7.87 (dd, J = 7.6, 1.6 Hz, 1H), 10.32 (s, 1H). 13C NMR (100.5 MHz) δ 42.8, 45.2, 57.1, 
63.6, 96.5, 123.0, 126.5, 127.5, 130.5, 131.1, 133.4, 134.3, 139.8, 140.0, 140.7, 153.6, 
192.5. IR (NaCl) ν 1693 cm-1. HRMS (ESI-TOF) cald for C18H22IN2O: 409.0771 
[M+H] +; found: 409.0774. 
4-Fluoro-2-[N-(2-iodophenyl)-N-methylaminomethyl]benzaldehyde (5). 
Chromatography: CH2Cl2. Green oil. 
1H NMR (400 MHz) δ 2.69 (s, 3H), 4.57 (s, 2H), 
6.82 (ddd, J = 8, 7.2, 1.6 Hz, 1H), 7.10 (td, J = 8, 2.8 Hz, 1H), 7.19 (dd, J = 8, 1.6 Hz, 
1H), 7.32 (ddd, J = 8, 7.2, 1.6 Hz, 1H), 7.66 (dd, J = 10.4, 2.4 Hz, 1H), 7.87 (m, 2H), 
10.18 (s, 1H). 13C NMR (100.5 MHz) δ 42.7, 57.2 (d, J = 1.5 Hz), 98.4, 114.4 (d, J = 
21.4 Hz), 117.4 (d, J = 22.9 Hz), 122.4, 126.0, 129.2, 130.6 (d, J = 2.3 Hz), 135.2 (d, J
= 9.9 Hz), 140.2, 144.8 (d, J = 8.4 Hz), 153.6, 166.0 (d, J = 255.8 Hz), 191.1. IR (NaCl) 
ν 1694 cm-1. HRMS (ESI-TOF) cald for C15H14FINO: 370.0099 [M+H]+; found: 
370.0096. 
2-[N-(tert-Butoxycarbonyl)-N-(2-iodophenyl)aminomethyl]benzaldehyde (6). A 
solution of N-(tert-butoxycarbonyl)-2-iodoaniline (0.4 g, 1.25 mmol) in THF (2 mL) 
was added at 0ºC under Argon to a suspension of NaH (60% in oil, 65 mg, 1.63 mmol) 
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in THF (8 mL). After 15 min at 25ºC, the mixture was cooled again to 0ºC. DMF (2 
mL) and 2-(bromomethyl)benzaldehyde (325 mg, 1.63 mmol) were added and the 
mixture was stirred for 10 min at 0ºC and at 25ºC overnight. Saturated aqueous NH4Cl 
was added and the mixture was extracted with EtOAc. The organic extracts were dried 
and concentrated. The residue was purified by chromat graphy (from hexanes to 8:2 
hexanes-EtOAc) to give 6 (265 mg, 48%) as an orange oil. 1H NMR (400 MHz, mixture 
of rotamers) δ 1.38 (s, 9H), 4.91 (d, J = 16 Hz, 1H), 5.48 (d, J = 16 Hz, 1H), 6.77-7.84 
(m, 8H), 10.12 (s, 1H). 13C NMR (100.5 MHz, major rotamer) δ 28.2, 48.6, 80.8, 100.3, 
127.9, 128.6, 128.8, 129.8, 130.7, 130.9, 133.7, 134.3, 139.6, 143.5, 153.9, 192.1. 
HRMS (ESI-TOF) cald for C19H21INO3: 438.0561 [M+H]
+; found: 438.0549. 
3-[N-(2-Iodophenyl)-N-methylaminomethyl]-2-naphthaldehyde (7). A mixture of 2-
iodo-N-methylaniline (150 g, 0.68 mmol), 3-(bromomethyl)-2-naphthaldehyde31 (115 
mg, 0.46 mmol) and 2,6-lutidine (80 µL ,0.68 mmol) was stirred at 100ºC for 6 h. The 
reaction mixture was partitioned between water and Et2O. The organic layer was dried 
and concentrated. The residue was purified by chromat graphy (from hexanes to 95:5 
hexanes-EtOAc) to give 7 (130 mg, 70%) as an orange oil. 1H NMR (300 MHz) δ 2.72 
(s, 3H), 4.70 (s, 2H), 6.80 (ddd, J = 7.8, 7.2, 1.5 Hz, 1H), 7.25 (dd, J = 7.8, 1.5 Hz, 1H), 
7.33 (ddd, J = 7.8, 7.2, 1.5 Hz, 1H), 7.54 (td, J = 7.2, 1.2 Hz, 1H), 7.62 (td, J = 7.2, 1.2 
Hz, 1H), 7.86 (dd, J = 7.8, 1.5 Hz, 1H), 7.90 (d, J = 7.8 Hz, 1H), 7.97 (d, J = 7.8 Hz, 
1H), 8.17 (s, 1H), 8.39 (s, 1H), 10.36 (s, 1H). 13C NMR (75.4 MHz) δ 43.0, 57.8, 98.5, 
122.4, 125.7, 126.7, 127.8, 129.1 (2 CH), 129.2, 129.4, 131.7, 132.7, 135.2, 135.3, 
135.5, 140.1, 154.0, 192.9. IR (NaCl) ν 1692 cm-1. HRMS (ESI-TOF) cald for 
C19H17INO: 402.0349 [M+H]
+; found: 402.0355. 
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2-[N-(3-Iodo-2-naphthyl)-N-methylaminomethyl]benzaldehyde (8). 
Chromatography: from hexanes to 95:5 hexanes-EtOAc. Yellow solid. 1H NMR (300 
MHz) δ 2.73 (s, 3H), 4.66 (s, 2H), 7.35-7.48 (m, 3H), 7.52 (s, 1H), 7.57 (ddd, J = 7.8, 
7.2, 1.5 Hz, 1H), 7.65 (d, J = 7.8 Hz, 1H), 7.72 (d, J = 8.1 Hz, 1H), 7.83 (d, J = 7.8 Hz, 
1H), 7.87 (dd, J = 7.8, 1.2 Hz, 1H), 8.40 (s, 1H), 10.32 (s, 1H). 13C NMR (75.4 MHz) δ 
43.3, 57.5, 98.0, 119.0, 125.4, 126.4, 126.7, 127.0, 127.5, 130.4, 131.7, 132.1, 133.5, 
133.6, 134.3, 139.7, 140.6, 150.5, 192.7. IR (NaCl) ν 1691 cm-1. HRMS (ESI-TOF) 
cald for C19H17INO: 402.0349 [M+H]
+; found: 402.0342. 
2-[N-(1-Iodo-2-naphthyl)-N-methylaminomethyl]benzaldehyde (9). 
Chromatography: from hexanes to 1:1 hexanes-CH2Cl2. Yellow oil. 
1H NMR (400 
MHz) δ 2.79 (s, 3H), 4.69 (s, 2H), 7.40-7.48 (m, 3H), 7.52-7.58 (m, 2H), 7.75 (dd, J = 
7.6, 0.8 Hz, 1H), 7.81 (d, J = 8.0 Hz, 1H), 7.82 (d, J = 7.6 Hz, 1H), 7.89 (dd, J = 7.6, 
1.2 Hz, 1H), 8.26 (d, J = 8.4 Hz, 1H), 10.40 (s, 1H). 13C NMR (100.5 MHz) δ 43.6, 
57.4, 103.5, 121.4, 125.7, 127.6, 127.8, 128.0, 129.8, 130.7, 131.5, 132.0, 132.9, 133.6, 
134.3, 135.9, 140.7, 152.3, 192.8. IR (NaCl) ν 1692 cm-1. HRMS (ESI-TOF) cald for 
C19H17INO: 402.0349 [M+H]
+; found: 402.0350. 
2-[N-(2-Iodo-1-naphthyl)-N-methylaminomethyl]benzaldehyde (10). 
Chromatography: from hexanes to 9:1 hexanes-EtOAc. Yellow oil. 1H NMR (300 MHz) 
δ 3.02 (s, 3H), 4.91 (d, J = 13.5 Hz, 1H), 4.97 (d, J = 13.5 Hz, 1H), 7.39 (d, J = 8.4 Hz, 
1H), 7.41-7.51 (m, 3H), 7.54 (td, J = 7.5, 1.5 Hz, 1H), 7.63 (d, J = 7.5 Hz, 1H), 7.82 (m, 
1H), 7.85 (d, J = 9 Hz, 1H), 7.87 (m, 1H), 8.05 (m, 1H), 20.21 (s, 1H). 13C NMR (100.5 
MHz) δ 40.6, 56.2, 97.3, 124.0, 126.2, 126.4, 127.5, 127.6, 128.5, 130.8, 131.2, 133.4, 
133.6, 134.3, 134.6, 136.5, 141.6, 149.5, 192.1. IR (NaCl) ν 1691 cm-1. HRMS (ESI-
TOF) cald for C19H17INO: 402.0349 [M+H]
+; found: 402.0340. 
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Representative Procedure for the Pd(0)-Catalyzed Acylation (Table 1, Entry 1). A 
mixture of aldehyde 1a (70 mg, 0.2 mmol), Cs2CO3 (195 mg, 0.6 mmol), Et3N (0.17 
mL, 1.2 mmol), Pd2(dba)3 (9 mg, 0.01 mmol), and dtpf (9.5 mg, 0.02 mmol) in toluene 
(8 mL) was stirred at 110°C in a sealed tube for 24 h. The reaction mixture was 
partitioned between water and Et2O. The organic extracts were washed with brine, 
dried, and concentrated. The residue was purified by chromatography (from hexanes to 
hexanes-EtOAc 2.5%) to give 11 (34 mg, 77%). 
6-Methyl-5,6-dihydrodibenzo[b,e]azepin-11-one (11). Yellow solid: mp 109-110 ºC 
(recrystallized from Et2O). 
1H NMR (300 MHz) δ 3.24 (s, 3H), 4.26 (s, 2H), 6.85 (m, 
1H), 6.87 (d, J = 7.8 Hz, 1H), 7.24 (dd, J = 7.2, 1.5 Hz, 1H), 7.34-7.43 (m, 2H), 7.49 
(td, J = 7.5, 1.5 Hz, 1H), 7.76 (dd, J = 7.5, 1.5 Hz, 1H), 8.30 (dd, J = 8.4, 1.5 Hz, 1H). 
13C NMR (75.4 MHz) δ 40.1, 58.4, 115.7, 117.5, 123.5, 125.6, 128.0, 128.9, 131.9, 
132.3, 134.1, 136.9, 140.5, 150.9, 193.4. IR (NaCl) ν 1629 cm-1. HRMS (ESI-TOF) 
cald for C15H14NO: 224.1070 [M+H]
+; found: 224.1069. 
6-Benzyl-9-methyl-5,6-dihydrodibenzo[b,e]azepin-11-one (12). Chromatography: 
from hexanes to hexanes-EtOAc 3%. Yellow solid: mp 85-90 ºC (recrystallized from 
Et2O). Yield: 91% (48 mg). 
1H NMR (300 MHz) δ 2.30 (s, 3H), 4.30 (s, 2H), 4.70 (s, 
2H), 6.80 (d, J = 8.4 Hz, 1H), 7.08 (dd, J = 7.5, 1.2 Hz, 1H), 7.15 (dd, J = 8.4, 2.4 Hz, 
1H), 7.22 (d, J = 7.2 Hz, 2H), 7.30-7.43 (m, 4H), 7.46 (td, J = 7.5, 1.5 Hz, 1H), 7.78 
(dd, J = 7.5, 1.2 Hz, 1H), 8.12 (d, J = 1.2 Hz, 1H). 13C NMR (75.4 MHz) δ 20.2, 55.4, 
55.9, 117.2, 123.5, 125.9, 126.7, 127.3, 127.4, 128.0, 128.8, 129.0, 131.5, 131.8, 135.6, 
136.7, 137.6, 140.7, 149.2, 193.6. IR (NaCl) ν 1633 cm-1. HRMS (ESI-TOF) cald for 
C22H20NO: 314.1545 [M+H]
+; found: 314.1548. 
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9-Methoxy-6-methyl-5,6-dihydrodibenzo[b,e]azepin-11-one (13). Chromatography: 
from hexanes to hexanes-EtOAc 5%. Brown solid: mp 95-97 ºC (recrystallized from 
Et2O). Yield: 60% (30 mg). 
1H NMR (300 MHz) δ 3.19 (s, 3H), 3.84 (s, 3H), 4.23 (s, 
2H), 6.88 (d, J = 9.0 Hz, 1H), 7.08 (dd, J = 9.0, 3.3 Hz, 1H), 7.24 (d, J = 7.8 Hz, 1H), 
7.38 (ddd, J = 7.8, 7.5, 1.2 Hz, 1H), 7.50 (dd, J = 7.8, 7.5, 1.5 Hz, 1H), 7.78 (d, J = 3.3 
Hz, 1H), 7.79 (d, J = 7.8 Hz, 1H). 13C NMR (75.4 MHz) δ 40.2, 55.6, 58.5, 112.1, 
118.2, 123.7, 124.3, 125.8, 127.9, 129.1, 131.9, 137.0, 139.9, 146.5, 151.8, 192.7. IR 
(NaCl) ν 1630 cm-1. HRMS (ESI-TOF) cald for C16H16NO2: 254.1176 [M+H]+; found: 
254.1182. 
8-Fluoro-6-methyl-5,6-dihydrodibenzo[b,e]azepin-11-one (14a). Chromatography: 
from hexanes to hexanes-EtOAc 10%. Yellow gum. Yield: 74% (36 mg). 1H NMR (300 
MHz) δ 3.23 (s, 3H), 4.28 (s, 2H), 6.51 (dd, J = 12.0, 2.4 Hz, 1H), 6.90 (ddd, J = 9.6, 
7.5, 2.4 Hz, 1H), 7.25 (d, J = 7.5 Hz, 1H), 7.39 (td, J = 7.5, 1.2 Hz, 1H), 7.51 (td, J = 
7.5, 1.5 Hz, 1H), 7.76 (dd, J = 7.5, 1.2 Hz, 1H), 8.32 (dd, J = 9.0, 7.5 Hz, 1H). 13C 
NMR (75.4 MHz) δ 40.3, 58.5, 101.2 (d, J = 25.9 Hz), 106.0 (d, J = 23.0 Hz), 120.4, 
125.7, 128.3, 129.0, 132.0, 135.4 (d, J = 11.5 Hz), 136.5, 140.3, 152.5 (d, J = 12.1 Hz), 
166.7 (d, J = 252.5 Hz), 192.0. IR (NaCl) ν 1633 cm-1. HRMS (ESI-TOF) cald for 
C15H13FNO: 242.0976 [M+H]
+; found: 242.0981. 
8-Cloro-6-methyl-5,6-dihydrodibenzo[b,e]azepin-11-one (14b). Chromatography: 
from hexanes to hexanes-EtOAc 8%. Brown solid: mp 86-8  ºC. Yield: 79% (35 mg). 
1H NMR (400 MHz) δ 3.24 (s, 3H), 4.26 (s, 2H), 6.82 (dd, J = 8.8, 2.0 Hz, 1H), 6.85 (s, 
1H), 7.25 (d, J = 7.6 Hz, 1H), 7.39 (dd, J = 8.0, 7.2 Hz, 1H), 7.51 (ddd, J = 7.6, 7.2, 1.2 
Hz, 1H), 7.75 (d, J = 8.0 Hz, 1H), 8.23 (d, J = 8.8 Hz, 1H). 13C NMR (100.5 MHz) δ 
40.2, 58.4, 115.1, 118.1, 122.0, 125.8, 128.3, 129.0, 132.2, 134.0, 136.6, 140.2, 140.3, 
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151.3, 192.3. IR (NaCl) ν 1630 cm-1. HRMS (ESI-TOF) cald for C15H13ClNO: 
258.0680 [M+H]+; found: 258.0678. 
8-(Hydroxymethyl)-6-methyl-5,6-dihydrodibenzo[b,e]azepin-11-one (14c). 
Chromatography: from CH2Cl2 to CH2Cl2-MeOH 1%. Yellow oil. Yield: 71% (32 mg). 
1H NMR (400 MHz) δ 2.39 (broad s, 1H), 3.22 (s, 3H), 4.20 (s, 2H), 4.67 (s, 2H), 6.77 
(dd, J = 8.0, 1.6 Hz, 1H), 6.89 (s, 1H), 7.22 (d, J = 7.6 Hz, 1H), 7.36 (td, J = 7.6, 1.2 
Hz, 1H), 7.48 (td, J = 7.6, 1.2 Hz, 1H), 7.74 (dd, J = 7.2, 1.2 Hz, 1H), 8.24 (d, J = 8.0 
Hz, 1H). 13C NMR (100.5 MHz) δ 40.1, 58.4, 64.7, 113.0, 115.8, 122.5, 125.7, 128.0, 
128.8, 132.0, 132.7, 136.8, 140.3, 147.6, 151.1, 193.1. IR (NaCl) ν 1623, 3406 cm-1. 
HRMS (ESI-TOF) cald for C16H16NO2: 254.1176 [M+H]
+; found: 254.1166. 
8-(Formyl)-6-methyl-5,6-dihydrodibenzo[b,e]azepin-11-one (14d). Chromatography: 
from hexanes to CH2Cl2. Yellow oil. Yield: 49% (22 mg). 
1H NMR (400 MHz) δ 3.35 
(s, 3H), 4.32 (s, 2H), 7.28 (d, J = 7.6 Hz, 1H), 7.32 (dd, J = 8.4, 1.6 Hz, 1H), 7.40 (s, 
1H), 7.41 (td, J = 7.6, 1.2 Hz, 1H), 7.55 (td, J = 7.6, 1.6 Hz, 1H), 7.75 (dd, J = 7.6, 1.2 
Hz, 1H), 8.43 (d, J = 8.0 Hz, 1H). 13C NMR (100.5 MHz) δ 40.3, 58.4, 117.2, 117.4, 
125.9, 126.8, 128.4, 129.0, 132.5, 133.5, 136.7, 139.8, 140.2, 150.8, 192.4, 193.3. IR 
(NaCl) ν 1633, 1693 cm-1. HRMS (ESI-TOF) cald for C16H14NO2: 252.1019 [M+H]+; 
found: 252.1016. 
8-(Acetoxymethyl)-6-methyl-5,6-dihydrodibenzo[b,e]azepin-11-one (14e). 
Chromatography: from hexanes to CH2Cl2. Yellow oil. Yield: 69% (32 mg). 
1H NMR 
(400 MHz) δ 2.12 (s, 3H), 3.26 (s, 3H), 4.26 (s, 2H), 5.08 (s, 2H), 6.83 (d, J = 7.6 Hz, 
1H), 6.85 (s, 1H), 7.24 (d, J = 7.2 Hz, 1H), 7.38 (td, J = 7.6, 1.2 Hz, 1H), 7.50 (td, J = 
7.6, 1.2 Hz, 1H), 7.75 (dd, J = 7.2, 1.2 Hz, 1H), 8.29 (d, J = 8.0 Hz, 1H). 13C NMR 
(100.5 MHz) δ 20.9, 40.1, 58.4, 65.8, 114.8, 116.9, 123.1, 125.7, 128.1, 128.9, 132.0, 
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132.9, 136.8, 140.3, 142.1, 150.8, 170.7, 192.9. IR (NaCl) ν 1632, 1738 cm-1. HRMS 
(ESI-TOF) cald for C18H18NO3: 296.1281 [M+H]
+; found: 296.1276. 
8-(Dimethylaminomethyl)-6-methyl-5,6-dihydrodibenzo[b,e]azepin-11-one (14f). 
Chromatography (SiO2, from CH2Cl2 to CH2Cl2-MeOH 3%). Yellow oil. Yield: 69% 
(28 mg). 1H NMR (400 MHz) δ 2.27 (s, 6H), 3.27 (s, 3H), 3.44 (s, 2H), 4.26 (s, 2H), 
6.81 (dd, J = 8.4, 1.6 Hz, 1H), 6.89 (s, 1H), 7.25 (d, J = 7.6 Hz, 1H), 7.38 (td, J = 7.6, 
1.2 Hz, 1H), 7.49 (td, J = 7.6, 1.2 Hz, 1H), 7.76 (dd, J = 7.6, 1.2 Hz, 1H), 8.25 (d, J = 
8.4 Hz, 1H). 13C NMR (100.5 MHz) δ 40.2, 45.4, 58.4, 64.2, 115.8, 118.6, 122.7, 125.7, 
128.0, 128.9, 131.9, 132.5, 136.9, 140.5, 145.1, 15.0, 193.0. IR (NaCl) ν 1633 cm-1. 
HRMS (ESI-TOF) cald for C18H21N2O: 281.1654 [M+H]
+; found: 281.1654. 
4-Fluoro-6-methyl-5,6-dihydrodibenzo[b,e]azepin-11-one (15). Chromatography: 
from hexanes to hexanes-CH2Cl2 80%. Yellow solid: mp 82-84 ºC. Yield: 87% (34 mg). 
1H NMR (400 MHz) δ 3.24 (s, 3H), 4.23 (s, 2H), 6.88 (m, 2H), 6.95 (dd, J = 8.8, 2.4 
Hz, 1H), 7.07 (td, J = 8.8, 2.4 Hz, 1H), 7.41 (ddd, J = 8.8, 7.2, 1.2 Hz, 1H), 7.79 (dd, J 
= 8.8, 5.6 Hz, 1H), 8.31 (dd, J = 8.8, 1.2 Hz, 1H). 13C NMR (100.5 MHz) δ 40.2, 58.0 
(d, J = 1.5 Hz), 112.6 (d, J = 21.8 Hz), 115.1 (d, J = 21.0 Hz), 115.9, 117.9, 123.5, 
131,7 (d, J = 9.2 Hz), 132.4, 134.2, 136.7 (d, J = 3.1 Hz), 139.3 (d, J = 7.0 Hz), 150.9, 
165.0 (d, J = 252.8 Hz), 191.6. IR (NaCl) ν 1633 cm-1. HRMS (ESI-TOF) cald for 
C15H13FNO: 242.0975 [M+H]
+; found: 242.0976. 
5-Methyl-5,6-dihydrobenzo[b]naphtho[2,3-e]azepin-13-one (16). Chromatography: 
from hexanes to hexanes-EtOAc 8%. Yellow oil. Yield: 61% (21 mg). 1H NMR (300 
MHz) δ 3.25 (s, 3H), 4.43 (s, 2H), 6.84-6.91 (m, 2H), 7.40 (ddd, J = 8.7, 6.9, 1.5 Hz, 
1H), 7.46-7.58 (m, 2H), 7.67 (s, 1H), 7.86 (d, J = 8.1 Hz, 1H), 7.92 (d, J = 8.1 Hz, 1H), 
8.29 (s, 1H), 8.35 (dd, J = 8.7, 1.5 Hz, 1H). 13C NMR (75.4 MHz) δ 39.9, 58.8, 115.8, 
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117.6, 123.7, 123.9, 126.3, 127.3, 127.8, 129.2, 129.7, 132.3, 132.6, 134.1, 134.4, 
134.9, 139.0, 151.2, 193.4. IR (NaCl) ν 1619, 1639 cm-1. HRMS (ESI-TOF) cald for 
C19H16NO: 274.1226 [M+H]
+; found: 274.1223. 
6-Methyl-6,7-dihydrobenzo[e]naphtho[2,3-b]azepin-12-one (17). Chromatography: 
from hexanes to 1:1 hexanes-CH2Cl2. Red oil. Yield: 58% (30 mg). 
1H NMR (300 
MHz) δ 3.28 (s, 3H), 4.30 (s, 2H), 7.08 (s, 1H), 7.22 (ddd, J = 8.4, 7.2, 1.2 Hz, 1H), 
7.27 (dd, J = 7.5, 0.9 Hz, 1H), 7.36-7.45 (m, 2H), 7.51 (td, J = 7.5, 1.5 Hz, 1H), 7.62 (d, 
J = 8.4 Hz, 1H), 7.83 (d, J = 7.5 Hz, 1H), 7.84 (dd, J = 7.5, 3.3 Hz, 1H), 8.29 (s, 1H). 
13C NMR (75.4 MHz) δ 40.9, 58.5, 109.7, 123.0, 125.7, 125.9, 126.6, 126.8, 128.0, 
128.8, 129.2, 129.8, 132.2, 134.5, 137.3, 138.2, 139.8, 147.4, 194.0. IR (NaCl) ν 1619, 
1643 cm-1. HRMS (ESI-TOF) cald for C19H16NO: 274.1226 [M+H]
+; found: 274.1224. 
7-Methyl-7,8-dihydrobenzo[e]naphtho[2,1-b]azepin-13-one (18). Chromatography: 
from hexanes to 1:1 hexanes-EtOAc. Yellow oil. Yield: 90% (46 mg). 1H NMR (400 
MHz) δ 3.29 (s, 3H), 4.32 (s, 2H), 7.10 (d, J = 8.8 Hz, 1H), 7.24 (d, J = 7.2 Hz, 1H), 
7.32 (ddd, J = 8.4, 7.2, 1.2 Hz, 1H), 7.37 (td, J = 7.6, 1.2 Hz, 1H), 7.46 (td, J = 7.6, 1.6 
Hz, 1H), 7.58 (ddd, J = 8.8, 7.2, 1.2 Hz, 1H), 7.65 (dd, J = 8.0, 1.2 Hz, 1H), 7.72 (d, J = 
9.2 Hz, 1H), 7.82 (dd, J = 8.0, 1.2 Hz, 1H), 9.32 (d, J = 8.4 Hz, 1H). 13C NMR (100.5 
MHz) δ 39.7, 58.0, 114.4, 117.0, 123.4, 124.8, 126.9, 127.7, 128.1, 128.2, 128.6, 129.0, 
130.8, 134.1, 135.1, 137.1, 142.1, 152.4, 191.9. IR (NaCl) ν 1603, 1635 cm-1. HRMS 
(ESI-TOF) cald for C19H16NO: 274.1226 [M+H]
+; found: 274.1228. 
13-Methyl-12,13-dihydrobenzo[e]naphtho[1,2-b]azepin-7-one (19). 
Chromatography: from hexanes to 1:1 hexanes-CH2Cl2. Yellow oil. Yield: 64% (30 
mg). 1H NMR (400 MHz) δ 2.93 (s, 3H), 4.60 (s, 2H), 7.33 (d, J = 7.6 Hz, 1H), 7.43 (t, 
J = 7.6 Hz, 1H), 7.49-7.59 (m, 4H), 7.80 (d, J = 7.6 Hz, 1H), 7.99 (d, J = 7.6 Hz, 1H), 
 22
8.36 (m, 2H). 13C NMR (100.5 MHz) δ 41.4, 59.0, 123.5, 125.9, 126.7, 127.2, 127.5, 
128.0, 128.2, 128.3, 128.5, 129.7, 130.5, 132.0, 137.5, 138.0, 139.9, 152.7, 192.4. IR 
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